Clovis Oncology - 48 Year Dividend History | CLVS

Historical dividend payout and yield for Clovis Oncology (CLVS) since 1971. The current TTM dividend payout for Clovis Oncology (CLVS) as of July 19, 2019 is $0.00. The current dividend yield for Clovis Oncology as of July 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.580B $0.095B
Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Clovis Oncology Inc. is headquartered in Colorado, USA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.806B 12.30
Gilead Sciences (GILD) United States $82.919B 10.07
CSL (CSLLY) Australia $35.794B 0.00
Bio-Techne Corp (TECH) United States $7.933B 54.13